New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt
Oncology July 08,2024
Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt
Oncology July 08,2024
Long-term study reveals more genetic mutations associated with aggressive prostate cancer

Long-term study reveals more genetic mutations associated with aggressive prostate cancer

byInstitute of Cancer ResearchXenograft model of prostate cancer. Credit: National Institutes of Health, 2015Scientists have added to the list of inherited genetic mutations known to increase th
Oncology July 08,2024
Long-term study reveals more genetic mutations associated with aggressive prostate cancer

Long-term study reveals more genetic mutations associated with aggressive prostate cancer

byInstitute of Cancer ResearchXenograft model of prostate cancer. Credit: National Institutes of Health, 2015Scientists have added to the list of inherited genetic mutations known to increase th
Oncology July 08,2024
Researchers discover novel way to make breast cancer cells die

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered
Oncology July 08,2024
Researchers discover novel way to make breast cancer cells die

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered
Oncology July 08,2024
New antibody harbors great potential for fighting blood cancer

New antibody harbors great potential for fighting blood cancer

byKiel UniversityCredit:Blood(2024). DOI: 10.1182/blood.2023021088Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occu
Oncology July 08,2024
New antibody harbors great potential for fighting blood cancer

New antibody harbors great potential for fighting blood cancer

byKiel UniversityCredit:Blood(2024). DOI: 10.1182/blood.2023021088Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occu
Oncology July 08,2024
Researchers develop scalable synthesis of cancer-fighting compounds

Researchers develop scalable synthesis of cancer-fighting compounds

byH. Lee Moffitt Cancer Center & Research InstituteCredit:Science Advances(2024). DOI: 10.1126/sciadv.adp9375Withanolides, a class of naturally occurring compounds found in plant
Oncology July 08,2024
Researchers develop scalable synthesis of cancer-fighting compounds

Researchers develop scalable synthesis of cancer-fighting compounds

byH. Lee Moffitt Cancer Center & Research InstituteCredit:Science Advances(2024). DOI: 10.1126/sciadv.adp9375Withanolides, a class of naturally occurring compounds found in plant
Oncology July 08,2024
Opportunistic colonizers: Selectively targeting tumor cells with bacteria

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac
Oncology July 08,2024
Opportunistic colonizers: Selectively targeting tumor cells with bacteria

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac
Oncology July 08,2024
Breakthrough research makes cancer-fighting viral agent more effective

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio
Oncology July 08,2024
Breakthrough research makes cancer-fighting viral agent more effective

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio
Oncology July 08,2024
Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre
Oncology July 08,2024
Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre
Oncology July 08,2024
Multiple myeloma: New insights into early detection of aggressive tumors

Multiple myeloma: New insights into early detection of aggressive tumors

byCharité - Universitätsmedizin BerlinIdentification of UBE2Q1 as a candidate protein for the aggressive phenotype of MM with gain/amp of chromosome 1q. Credit:Nature Cancer(2024). D
Orthopedics & Sports medicine July 08,2024
Multiple myeloma: New insights into early detection of aggressive tumors

Multiple myeloma: New insights into early detection of aggressive tumors

byCharité - Universitätsmedizin BerlinIdentification of UBE2Q1 as a candidate protein for the aggressive phenotype of MM with gain/amp of chromosome 1q. Credit:Nature Cancer(2024). D
Orthopedics & Sports medicine July 08,2024
Chemo drug may cause significant hearing loss in longtime cancer survivors

Chemo drug may cause significant hearing loss in longtime cancer survivors

byUniversity of South FloridaCredit: Unsplash/CC0 Public DomainAn interdisciplinary study led by researchers at the University of South Florida and Indiana University has uncovered significant f
Oncology July 08,2024
Chemo drug may cause significant hearing loss in longtime cancer survivors

Chemo drug may cause significant hearing loss in longtime cancer survivors

byUniversity of South FloridaCredit: Unsplash/CC0 Public DomainAn interdisciplinary study led by researchers at the University of South Florida and Indiana University has uncovered significant f
Oncology July 08,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com